MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2's Selective NMDA Binding Mechanism of Action.
Pharmaceuticals Company Releases Positive Preclinical Study Data For Neurological Disorder Treatment
Pharmaceuticals Company Releases Positive…
Pharmaceuticals Company Releases Positive Preclinical Study Data For Neurological Disorder Treatment
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2's Selective NMDA Binding Mechanism of Action.